SynBiotic SE (ETR:SBX)
3.050
-0.080 (-2.56%)
Apr 24, 2025, 5:36 PM CET
SynBiotic SE Employees
SynBiotic SE had 55 employees as of December 31, 2023. The number of employees decreased by 49 or -47.12% compared to the previous year.
Employees
55
Change (1Y)
-49
Growth (1Y)
-47.12%
Revenue / Employee
€70,206
Profits / Employee
€193,284
Market Cap
21.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 55 | -49 | -47.12% |
Dec 31, 2022 | 104 | 1 | 0.97% |
Dec 31, 2021 | 103 | 74 | 255.17% |
Dec 31, 2020 | 29 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Merck KGaA | 59,020 |
Siemens Healthineers AG | 72,000 |
Fresenius SE & Co. KGaA | 176,486 |
Bayer Aktiengesellschaft | 90,587 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
SynBiotic SE News
- 6 weeks ago - EQS-News: Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin - Wallstreet:Online
- 3 months ago - EQS-News: SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 - Wallstreet:Online
- 4 months ago - EQS-News: Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis - Wallstreet:Online
- 5 months ago - EQS-News: SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry - Wallstreet:Online
- 5 months ago - EQS-News: In full bloom: WEECO Pharma boosts SYNBIOTIC's sales - Wallstreet:Online
- 7 months ago - EQS-News: Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval - Wallstreet:Online
- 7 months ago - Original-Research: SynBiotic SE (von NuWays AG): BUY - Wallstreet:Online
- 7 months ago - SynBiotic transformation: Reaching new operational high(t)s - Wallstreet:Online